Summary
In a group of 241 patients with non-Hodgkin lymphoma investigated retrospectively, CNS manifestations occurred in 8%, mainly as meningeosis lymphoblastomatosa. Lymphoblastic and immunoblastic NHL showed the highest risk of CNS infiltration (40.7% and 12.5% respectively). Further risk factors were disseminated stage of the disease, prior involvement of the bone marrow and juvenile age. Characteristic symptoms were eye muscle paresis, paresthesias and pareses of peripheral muscles. The most fruitful diagnostic measure was lumbar puncture. More than 80% of the patients observed with CNS manifestations died within one year. The factor limiting life was less the CNS infiltration itself than the systemic progression. CNS prophylaxis should be incorporated in the treatment plan in patients with lymphoblastic and immunoblastic non-Hodgkin lymphoma at an early stage. In contrast CNS prophylaxis is not justified in uncontrollable systemic non-Hodgkin lymphoma spread.
Similar content being viewed by others
References
Lennert K (1978) Malignant lymphomas other than Hodgkin's disease. In: Uehlinger E (ed), Handbuch der speziellen pathologischen Anatomie und Histologie, Vol I, Part III B. Springer Berlin Heidelberg New York
Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnig JA (1974) Letter. Lancet 2:406–408
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860–1861
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219–234
Bunn Jr. PA, Schein PS, Banks PM, DeVita Jr. VT (1976) Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: Leukemia revisited. Blood 47:3–10
Burgener FA, Hamlin DJ (1981) Radiologic manifestation of histiocytic lymphoma in the sceletal and central nervous system. Fortschr Roentgenstr 134:50–55
Cetto GL, Iannuci A, Tummarello D, Rizzuto N, Scabbioni R, Menestrina F (1981) Involvement of the central nervous system in non-Hodgkin's lymphoma. Tumori 67:39–44
Coleman CN, Cohen JR, Burke JS, Rosenberg SA (1981) Lymphoblastic lymphoma in adults: Results of a pilot protocol. Blood 57:679–684
Delbrück H, Wetter O, Schmidt CG, Weichert HC, Schmitt G (1977) Die Meningeosis neoplastica und ihre Prophylaxe bei malignen Non-Hodgkin-Lymphomen. Dtsch Med Wochenschr 102:1446–1451
Gendelman S, Rizzo F, Mones RJ (1969) Central nervous system complications of leukemic conversion of the lymphomas. Cancer 24:676–682
Gerlach H, Jänisch W, Schreiber D, Feist H, Wessel H (1980) Beteiligung des Zentralnervensystems bei generalisierten Nicht-Hodgkin-Lymphomen. Arch Geschwulstforsch 50:1–10
Griffin JW, Thompson RW, Mitchinson MJ, de Kiewiet JC, Welland FH (1971) Lymphomatous leptomeningitis. Am J Med 51:200–208
Hansen MM, Baadsgaard B, Videbaek A (1976) Diffuse lymphosarcomatous infiltration in the central nervous system. Scand J Hematol 16:70–74
Herman TS, Hammond N, Jones SE, Butler JJ, Byrne Jr. GE, McKelvey EM (1979) Involvement of the central nervous system by non-Hodgkin's-lymphoma. Cancer 43:390–397
Jänisch W, Gerlach H, Remus I (1975) Neoplastic involvement of the CNS in generalized lymphomas. Acta Neuropathol (Berl) [Suppl VI]:81–84
Janota I (1966) Involvement of the nervous system in malignant lymphoma in Nigeria. Br J Cancer 20:47–61
Jellinger K (1979) Maligne Lymphome des Zentralnervensystems. In: Lymphknotentumoren. Stacher A, Höcker P (Hrsg) Urban und Schwarzenberg, München, S 240–247
John HT, Nabarro DN (1955) Intracranial manifestations of malignant lymphoma. Br J Cancer 9:386–400
Law IP, Dick FR, Blom J, Bergevin PR (1975) Involvement of the central nervous system in non-Hodgkin's lymphoma. Cancer 36:225–231
Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC (1980) CNS-involvement in the non-Hodgkin's lymphomas. Cancer 45:545–552
Litam JP, Cabanillas F, Smith TL, Bodey FP, Freireich EJ (1979) Central nervous system relapse in malignant lymphomas. Risk factors and implications for prophylaxis: Blood 54:1249–1257
Longpre B, Lamarche J, Rochon M, Lepine M (1978) Involvement of the nervous system in non-Hodgkin's lymphomas. In: Mathé G, Seligmann M, Tubiana M (eds) Lymphoid neoplasias II. Clinical and therapeutic aspects. Springer, Berlin Heidelberg New York, pp 81–87
Monfardini S, Ficarra G, Giardini R, Santoro A (1981) Central nervous system involvement in non-Hodgkin's lymphomas. Value of lumbar puncture as initial staging procedure. Tumori 67:197–202
Mullins GM, Flynn JP, El-Mahdi AM, McQueen JD, Owens AH (1971) Malignant lymphoma of the spinal epidural space. Ann Intern Med 74:416–423
Rosenberg SA, Diamond HD, Haslowitz B, Craver LF (1961) Lymphosarcoma. A review of 1269 cases. Medicine (Baltimore) 40:31–84
Routh A (1980) Non-Hodgkin's lymphoma of the spinal cord. CA 30:123–125
Sparling Jr. HJ, Adams RD, Parker F (1947) Involvement of the central nervous system by malignant lymphoma. Medicine (Baltimore) 26:285–332
Venables GS, Proctor SJ, Bates D, Cartlidge NE, Shaw DA (1980) Intracranial disease in non-Hodgkin's lymphoma. Q J Med, new series XLIX 194:111–131
Wessel H (1978) Beteiligung des Zentralnervensystems bei generalisierten Nicht-Hodgkin-Lymphomen. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Springer, Berlin Heidelberg New York, pp 249–250
Young RC, Howser DM, Anderson T, Fisher RI, Jaffe E, DeVita VT Jr (1979) Central nervous system complications of non-Hodgkin's lymphoma. Am J Med 66:435–443
Ziegler JL, Bluming AZ, Morrow RH, Fass L, Carbone PP (1970) Central nervous system involvement in Burkitt's lymphoma. Blood 36:718–728
Zimmermann HM (1975) Malignant lymphomas of the nervous system. Acta Neuropathol (Berlin) [Suppl VI]:69–74
Brittinger G, Bartels H, Bremer K, Burger A, Dühmke E, Gunzer U, König E, Stacher A, Stein H, Theml H, Waldner R (1977) Retrospektive Untersuchungen zur klinischen Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Strahlentherapie 153:222–228
Brittinger G, Schmalhorst U, Bartels H, Fülle HH, Gerhartz H, Gremmel G, Grisar T, Grupp HJ, Gunzer U, Huhn D, Koeppen KM, Kubanek B, Leopold H, Löffler H, Löhr GW, Nowicki L, Rühl U, Schmidt M, Stacher A, Theml H, Lennert K (1981) Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel Classification. Blut 43:155–166
Crowther D (1980) Lymphoma. In: Pinedo HM (ed) Cancer chemotherapy 1980. The EORTC cancer chemotherapy annual 2. Excerpta Medica, Amsterdam, pp 208–249
Stacher A, Bartels H, Bremer K, Brunswicker F, Common H, Fülle HH, Gunzer U, Leopold H, Nowicki L, Ocrter D, Pralle H, Theml H, Waldner R (1978) Klinik und Prognose der lymphoplasmazytoiden malignen Lymphome (Immunozytome). In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Springer, Berlin Heidelberg New York, pp 218–223
Gétaz EP, Miller GJ (1979) Spinal cord involvement in chronic lymphocytic leukemia. Cancer 43:1858–1861
Reske-Nielsen E, Petersen JH, Sogaard H, Jensen KB (1974) Leukemia of the central nervous system. Lancet 1:211–212
Bigner SH, Johnston WW (1981) The cytopathology of cerebrospinal fluid. I. Nonneoplastic conditions, lymphoma and leukemia. Acta Cytopathol 25:335–353
Rawlingson DG, Billingham ME, Berry PF, Kempson RL (1975) Cytology of the cerebrospinal fluid in patients with Hodgkin's disease or malignant lymphoma. Acta Neuropathol (Berl) [Suppl VI]:187–191
DeVita VT, Canellos GP (1966) Hypoglycorrhachia in meningeal carcinomatosis. Cancer 19:691–694
McMenemey WH, Cummings JN (1959) The value of the examination of the cerebrospinal fluid in the diagnosis of intracranial tumors. J Clin Pathol 12:400–411
Dubois PJ, Martinez AJ, Myerowitz RL, Rosenbaum AE (1978) Subependymal and leptomeningeal spread of systemic malignant lymphoma demonstrated by cranial computed tomography. J Comput Assist Tomogr 1:218–221
Conrad WC, Tetalman MR, Lloyd TV, King G, Scheu JD, Burton M, Schaeffer P (1978) Ventricular uptake during brain scanning. Radiology 128:428
Gasparini M, Lombardi F, Bellani FF, Gianni C, Pilotti S, Rilke F (1981) Childhood non-Hodgkin's lymphoma: Long-term results of an intensive chemotherapy regimen. Cancer 48:1508–1512
Mackintosh RF, Colby TV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, Rosenberg SA, Kaplan HS (1982) Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases. Cancer 49:586–595
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Freund, M., Ostendorf, P., Gärtner, V.H. et al. CNS manifestations in non-Hodgkin lymphomas (NHL). Klin Wochenschr 61, 903–909 (1983). https://doi.org/10.1007/BF01537530
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01537530